Medicare Enrolled
Dr. Suresh Ratnam, MD
Medical Oncology · Mcallen, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ratnam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ratnam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ratnam
Dr. Suresh Ratnam is a medical oncology specialist in Mcallen, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ratnam performed 21,108 Medicare services across 2,563 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ratnam received a total of $3,000,457 from 47 pharmaceutical and/or device companies across 3167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ratnam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 35% volume in TX
$3,000,457 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,108
Medicare services
Top 35% in TX for medical oncology
2,563
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
7,650 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 3,400 | $43 | $136 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,900 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,151 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,098 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
938 | $10 | $64 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
920 | $7 | $28 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
828 | $6 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
435 | $91 | $368 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
334 | $13 | $60 |
| Iron level test | 334 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
334 | $9 | $35 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
238 | $0 | $1 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
147 | $120 | $496 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
142 | $2 | $13 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
141 | $35 | $143 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
131 | $7 | $29 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 117 | $91 | $657 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
108 | $1,099 | $4,802 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
85 | $12 | $108 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
76 | $11 | $96 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
76 | $97 | $707 |
| New patient office visit, complex (60-74 min) | 63 | $140 | $709 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
61 | $76 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $66 | $250 |
| PSA test (prostate cancer screening) | 50 | $18 | $94 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
42 | $18 | $114 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
33 | $48 | $313 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
30 | $49 | $344 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
27 | $22 | $157 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
25 | $21 | $161 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
20 | $51 | $821 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
20 | $1 | $7 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
19 | $55 | $211 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
18 | $16 | $100 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
17 | $46 | $686 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
16 | $175 | $1,067 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
14 | $1,109 | $4,929 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
11 | $5 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.1% high complexity
33.2% medium
29.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,000,457
Total received (2018-2024)
Avg $428,637/year across 7 years
Top 0% in TX for medical oncology
47
Companies
3,167
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,952,660 (98.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,232 (1.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,565 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$490,034
2023
$614,508
2022
$504,059
2021
$354,654
2020
$218,257
2019
$489,271
2018
$329,673
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$613,060
Incyte Corporation
$524,200
Exelixis Inc.
$328,624
Lilly USA, LLC
$295,782
Puma Biotechnology, Inc.
$186,112
Rigel Pharmaceuticals, Inc.
$174,523
Pharmacosmos Therapeutics Inc.
$137,320
E.R. Squibb & Sons, L.L.C.
$137,020
Daiichi Sankyo Inc.
$113,414
JAZZ PHARMACEUTICALS INC.
$112,794
PUMA BIOTECHNOLOGY, INC.
$60,700
Genentech USA, Inc.
$59,954
Karyopharm Therapeutics Inc.
$53,996
Taiho Oncology, Inc.
$35,959
AMAG Pharmaceuticals, Inc.
$35,062
Helsinn Therapeutics (U.S.), Inc.
$31,805
Mirati Therapeutics, Inc.
$29,241
Stemline Therapeutics Inc.
$28,152
Verastem, Inc.
$10,418
Novocure Inc.
$6,923
EMD Serono, Inc.
$6,922
Novartis Pharmaceuticals Corporation
$6,899
Kite Pharma, Inc.
$4,176
Coherus Biosciences Inc.
$1,688
Foundation Medicine, Inc.
$1,370
Celgene Corporation
$1,270
TAIHO ONCOLOGY, INC.
$1,100
Takeda Pharmaceuticals U.S.A., Inc.
$196
Tempus AI, Inc
$185
GlaxoSmithKline, LLC.
$165
Adaptive Biotechnologies Corporation
$161
Sirtex Medical Inc
$149
PFIZER INC.
$148
Regeneron Healthcare Solutions, Inc.
$132
Epizyme, Inc.,
$125
Merck Sharp & Dohme Corporation
$116
Janssen Biotech, Inc.
$108
Janssen Scientific Affairs, LLC
$97
Astellas Pharma US Inc
$93
DAVOL INC.
$61
Seagen Inc.
$58
Amgen Inc.
$54
Gilead Sciences, Inc.
$43
Eisai Inc.
$26
Medtronic, Inc.
$23
Roche Diagnostics Corporation
$18
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 48.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ATACAND · Alecensa · BLENREP · Bavencio · CABOMETYX · CALQUENCE · CD Middleware Solutions · CYRAMZA · Cabometyx · Copiktra · DARZALEX · EMPLICITI · ENHERTU · ERLEADA · Enhertu · FERAHEME · FOUNDATIONACT · IBRANCE · ICLUSIG · IMFINZI · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · NINLARO · Nerlynx · OJJAARA · OPDIVO · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · PADCEV · PEMAZYRE · PROMACTA · Pomalyst · REBLOZYL · RETEVMO · Rezlidhia · SCEMBLIX · SIR-Spheres Microspheres · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TRUSELTIQ · TUKYSA · Tarceva · Tavalisse · VERZENIO · XPOVIO · XTANDI · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for medical oncology in TX.
Equivalent to $14,215 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
10
Per 100K population
1.1
County median income
$52,281
Nearest hospital
RIO GRANDE REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ratnam is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ratnam experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ratnam performed 7,650 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ratnam receive payments from pharmaceutical companies?
Yes. Dr. Ratnam received a total of $3,000,457 from 47 companies across 3,167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ratnam's costs compare to other medical oncologists in Mcallen?
Dr. Ratnam's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ratnam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Mcallen
Browse medical oncologists in Mcallen ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology